Weikaier Pharmaceutical Technology is based in Suzhou, China. Weikaier Pharmaceutical Technology has raised $63M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in January 2024. The round record for Weikaier Pharmaceutical Technology runs through 2024; nothing later has been disclosed. Investors on record include Ruixing Investment Management.
Weikaier Pharmaceutical Technology at a glance
Total raised
$63M
Latest round
Series C
Latest round date
January 2024
Headquarters
Suzhou, China
Notable investors
Ruixing Investment Management
Frequently asked about Weikaier Pharmaceutical Technology funding
How much has Weikaier Pharmaceutical Technology raised?
Weikaier Pharmaceutical Technology has raised $63M in total disclosed funding across the rounds on record.
Who has invested in Weikaier Pharmaceutical Technology?
Ruixing Investment Management are named among the investors backing Weikaier Pharmaceutical Technology.
What was the latest Weikaier Pharmaceutical Technology funding round?
The most recent disclosed round is a Series C, announced in January 2024.
Where is Weikaier Pharmaceutical Technology based?
Weikaier Pharmaceutical Technology is based in Suzhou, China.
When did Weikaier Pharmaceutical Technology last raise?
The last disclosed Weikaier Pharmaceutical Technology round closed in January 2024 at Series C.
Weikaier Pharmaceutical Technology totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Suzhou below to benchmark round size and investor mix.
Companies related to Weikaier Pharmaceutical Technology (18)
